US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Novo Nordisk A/S B Shares ADRhedged

24.51

0.0000

Volume:53

Turnover:1.33K

Market Cap:3.92M

PE:- -

High:24.51

Open:24.51

Low:24.51

Close:24.51

52wk High:34.36

52wk Low:19.00

Shares:160.00K

Float Shares:160.00K

Volume Ratio:0.83

T/O Rate:0.03%

Dividend:1.69

Dividend Rate:6.91%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Novo Nordisk Sues Eli Lilly in U.S. Federal Court, Alleging Claim Under the Lanham Act, Court Records Show

THOMSON REUTERS

The world is desperate for weight-loss drugs. But Big Pharma can’t advertise them

Novo Nordisk price target raised to DKK 330 from DKK 290 at Citi

Novo Nordisk A/S Stock Falls Monday, Underperforms Market

Update: Novo Nordisk's Wegovy Approved in India for Fatty Liver Disease Treatment

MT Newswires Live

Novo Nordisk (0QIU) Receives a Hold from Deutsche Bank

Novo Nordisk Guidance in Focus

Trump's FDA May Soon Back Peptides. Should You Buy In?

Novo Nordisk’s CagriSema Trial Wraps Up: What Completed Phase 3 Data Could Mean for NVO

Novo Nordisk to Launch Lower-cost Ozempic Copy in South Africa

Novo Nordisk A/S Stock Falls Friday, Underperforms Market

European Equities Mixed in Friday Trading; ASML to Give Staff One-Time Bonus

MT Newswires Live

European Pharma Stocks' Underperformance Shouldn't Last

Market Chatter: Novo Nordisk's Wegovy Approved for Fatty Liver Disease Treatment by India's Drug Regulator

MT Newswires Live

Cboe data shows mixed options sentiment in Novo Nordisk with shares up 2.11%

European Equities Traded in the US as American Depositary Receipts Edge Lower Thursday

MT Newswires Live

South Korea Implements New Rules to Curb Risks from Single-Stock Leveraged ETFs

United Laboratories Unit Receives $13.5 Million Milestone Payment From Novo Nordisk

MT Newswires Live

United Laboratories Secures Novo Nordisk Milestone for Obesity Drug UBT251

Moderately bullish activity in Novo Nordisk with shares up 2.46%

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/NVOH/news?page=10"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NVOH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NVOH\",,,,,undefined,":{"symbol":"NVOH","market":"US","secType":"STK","nameCN":"Novo Nordisk A/S B Shares ADRhedged","latestPrice":24.5091,"timestamp":1788356416526,"preClose":24.5091,"halted":0,"volume":53,"delay":0,"changeRate":0,"floatShares":160001,"shares":160001,"eps":0,"marketStatus":"Trading","change":0,"latestTime":"09-02 09:41:24 EDT","open":24.5091,"high":24.5091,"low":24.5091,"amount":1327.3528820000001,"amplitude":0,"askPrice":25.37,"askSize":100,"bidPrice":25.29,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1788379200000},"marketStatusCode":2,"adr":0,"exchange":"ARCA","adjPreClose":24.5091,"nav":24.588712,"aum":3934218.508712,"dividendRate":0.069129,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":24.73,"preClose":24.5091,"latestTime":"16:15 EDT","volume":8,"amount":196.0728,"timestamp":1788293700238,"change":0.2209,"changeRate":0.009013,"amplitude":0},"volumeRatio":0.826139,"impliedVol":0.1724,"impliedVolPercentile":0.3832},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NVOH\",,,,,undefined,":{"symbol":"NVOH","floatShares":160001,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.826139,"shares":160001,"dividePrice":1.6943,"high":24.5091,"amplitude":0,"preClose":24.5091,"low":24.5091,"week52Low":19,"pbRate":"--","week52High":34.36,"institutionHeld":0,"latestPrice":24.5091,"eps":0,"divideRate":0.069129,"volume":53,"delay":0,"ttmEps":0,"open":24.5091,"prevYearClose":27.4362,"prevWeekClose":24.7751,"prevMonthClose":24.5859,"prevQuarterClose":26.0576,"fiveDayClose":25.4775,"twentyDayClose":24.0037,"sixtyDayClose":23.0466},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NVOH\",params:#limit:5,,,undefined,":[{"date":"2026-06-16","symbol":"NVOH","amount":0.76666,"announcedDate":"2026-06-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-16","defaultRemindTime":1781616600000,"name":"Novo Nordisk A/S B Shares ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-23","payableDate":"2026-06-16","currency":"USD","dateTimestamp":1781582400000,"payDate":"2026-06-23"},{"date":"2026-03-16","symbol":"NVOH","amount":0.27495,"announcedDate":"2026-03-13","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-16","defaultRemindTime":1773667800000,"name":"Novo Nordisk A/S B Shares ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-23","payableDate":"2026-03-16","currency":"USD","dateTimestamp":1773633600000,"payDate":"2026-03-23"},{"date":"2025-12-16","symbol":"NVOH","amount":0.48798,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"Novo Nordisk A/S B Shares ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-24"},{"date":"2025-09-16","symbol":"NVOH","amount":0.16566,"announcedDate":"2025-09-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-16","defaultRemindTime":1758029400000,"name":"Novo Nordisk A/S (B Shares) ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-23","payableDate":"2025-09-16","currency":"USD","dateTimestamp":1757995200000,"payDate":"2025-09-23"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NVOH\",market:\"US\",,,undefined,":[{"executeDate":"2025-09-16","recordDate":"2025-09-16","paymentDate":"2025-09-23","value":0.16566,"currency":"USD"},{"executeDate":"2025-12-16","recordDate":"2025-12-16","paymentDate":"2025-12-24","value":0.48798,"currency":"USD"},{"executeDate":"2026-03-16","recordDate":"2026-03-16","paymentDate":"2026-03-23","value":0.27495,"currency":"USD"},{"executeDate":"2026-06-16","recordDate":"2026-06-16","paymentDate":"2026-06-23","value":0.76666,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NVOH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NVOH\",pageSize:20,pageCount:10,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2653274187","title":"Novo Nordisk Sues Eli Lilly in U.S. Federal Court, Alleging Claim Under the Lanham Act, Court Records Show","url":"https://stock-news.laohu8.com/highlight/detail?id=2653274187","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653274187?lang=en_us&edition=fundamental","pubTime":"2026-07-21 19:32","pubTimestamp":1784633544,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260721:nL6N43N0PN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4534","LU2023251221.USD","LU0266013472.USD","LU1720051108.HKD","LU0889565916.HKD","LU1366192091.USD","MEDX","RXL","LU0787776722.HKD","LU0708995401.HKD","LU0345770993.USD","BK4581","LU0198837287.USD","LU1983299246.USD","SG9999014914.USD","LU2471134796.USD","LU0122379950.USD","LU1629891620.HKD","LU2462591350.SGD","LU2023250504.SGD","LU2417539215.USD","SGXZ81514606.USD","BK4585","LU1989771016.USD","LU2461242641.AUD","LU0133085943.USD","LU2112291526.USD","LU0683600562.USD","LU0820562030.AUD","LU1093756168.USD","NVOH","LU2168563687.JPY","IE00BK4W5L77.USD","LU1127390331.HKD","IYH","LU0471298777.SGD","LU0079474960.USD","LU0672654240.SGD","LU0823434740.USD","IE00B4JS1V06.HKD","LU2896262040.SGD","IE00B1XK9C88.USD","LU1023059063.AUD","IE00B1BXHZ80.USD","NVO","HRTS","LU2361044949.HKD","LU1868837136.USD","LU2491049909.HKD","LU2552382215.SGD","CANC","LU1720051017.SGD","LU0238689110.USD","LU1988902786.USD","LU0058720904.USD","LU0354030438.USD","CURE","SG9999001176.SGD","BK4007","IE0004445015.USD","LU0820561909.HKD","LU0943347566.SGD","BK4533","IE00BJLML261.HKD","LLII","IE00BFSS8Q28.SGD","SG9999015945.SGD","LLY","LU0174119429.USD","LU1868836591.USD","IE00BFTCPJ56.SGD","LU2213496289.HKD","LU0823434583.USD","LU2756315318.SGD","BK4588","LU1868836914.USD","IE0002141913.USD","LU2357305700.SGD","MEDI","LU2106854487.HKD","IXJ","LU1064131342.USD","LU1551013342.USD","LU2237443895.HKD","SGXZ57979304.SGD","LU2168564065.EUR","LU0466842654.USD","LU0786609619.USD","LU2211815571.USD","LU2264538146.SGD","LU0471298694.HKD","LU0820561818.USD","LU1057294990.SGD","LU1548497426.USD","LU0256863811.USD","LU2237443978.SGD","LU2324357040.USD","IE00BZ1G4Q59.USD","LU2602419157.SGD","LU1974910355.USD","SG9999015952.SGD","SG9999015986.USD","LU2491050071.SGD","SGXZ99366536.SGD","LU1623119135.USD","BK4516","SG9999017495.SGD","IE00B2B36J28.USD","IE00BKPKM429.USD","XLV","LU1291159041.SGD","AGNG","LU2361045086.USD","LU0316494557.USD","LU1280957306.USD","LU2237443622.USD","LU2237438978.USD","LU2471134879.HKD","IE00BKVL7J92.USD","LU1712237335.SGD","LU2271345857.HKD","IE0005OL40V9.USD","LU0109394709.USD","LU1551013425.SGD","LLYX","LU2168564149.EUR","LU2746668974.SGD","LU2756315664.SGD","PPH","SG9999014880.SGD","GDOC","IE00BJJMRX11.SGD","LU0432979614.USD","LU2089283258.USD","LU0354030511.USD","LU0417517546.SGD","LU2168564495.EUR","LU2750360641.GBP","MHIP","ELIL","ELIS","IE0009355771.USD","NVOX","LU0353189680.USD","LU1145028129.USD","LU2491050154.USD","SGXZ51526630.SGD","LU2471134952.CNY","IE00BWXC8680.SGD","LU0964807845.USD","LU2168564222.USD","LU2237443549.SGD","LU0256863902.USD","LU1804176565.USD","TRUH","OZEM","IE00BKDWB100.SGD","VHT","IHE","LU0456855351.SGD","LU1917777945.USD","LU0006306889.USD","JDOC","IE00BJJMRY28.SGD","SG9999001176.USD","SG9999015978.USD","IE00BJT1NW94.SGD","LU1061106388.HKD","SG9999018865.SGD","ILDR","LU2089984988.USD","GB00BDT5M118.USD","IE00B775H168.HKD","IE0001KFT4U8.USD","LU1232071149.USD","LU2237443465.HKD","LU2456880835.USD","LU1868836757.USD","LU2746668461.USD","LU2087625088.SGD","LU0154236417.USD","LU0234572021.USD","BK4599","LU0689472784.USD","LU0061475181.USD","IE00B7KXQ091.USD","LU0225283273.USD","LU1093756325.SGD","LU2111349929.HKD","LU2063271972.USD","IE0004445239.USD","LU0882574055.USD","LU2750360997.AUD","THNR","WDNA","LU0097036916.USD","BK4532","SG9999018857.SGD","LU0094547139.USD","LU0203202063.USD","IE00BN29S564.USD","LU1035775433.USD","LU2360106947.USD","SG9999013999.USD","LU2361044865.SGD","LU1814569148.SGD","LU2237443382.USD","SG9999014898.SGD","LU0106261372.USD","LU1069344957.HKD","LU1267930730.SGD","LU2028103732.USD","LU0823416689.USD","LU2023250330.USD","SGXZ31699556.SGD","LU0210536198.USD","IE00BJJMRZ35.SGD","SG9999014906.USD","LU0114720955.EUR","LU0640476718.USD","LU0385154629.USD","LU1323610961.USD","LU2089284900.SGD","FTXH","LU2462157665.USD","LU0345770308.USD","LU2236285917.USD","LU2265009873.SGD","LU2468319806.SGD","FHLC","LU0109391861.USD","LU0203201768.USD","IE00BK4W5M84.HKD","LU0882574139.USD","TMED","LU0158827948.USD","LU0320765992.SGD","LU0353189763.USD","LU2471134523.USD","LU0096364046.USD","LU0158827781.USD","LU1868837300.USD","IE00B4R5TH58.HKD","LU2108987350.USD","LU2552382058.USD","LU0320765059.SGD","LU2552382132.HKD","IE00BFSS7M15.SGD","PJP","LU0323591593.USD","LU0289739699.SGD","LLYZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653274378","title":"The world is desperate for weight-loss drugs. But Big Pharma can’t advertise them","url":"https://stock-news.laohu8.com/highlight/detail?id=2653274378","media":"CNN Business","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653274378?lang=en_us&edition=fundamental","pubTime":"2026-07-21 19:06","pubTimestamp":1784631960,"startTime":"0","endTime":"0","summary":"The temperature was 92 degrees Fahrenheit. The sweat, profuse. And I was walking toward an exhibition about the “obesity experience” on London’s bustling riverside funded by a $220 billion pharmaceutical company.It was day two of two. In a few hours’ time, the exhibition, designed as a maze, would be gone. And so too would be my chance to see, up close, the promotional gymnastics of a booming weight-loss drug industry bound by strict laws around what it can – and absolutely cannot – say to the British public.When I appeared at the mouth of the maze, a green T-shirted man explained that he was from Danish drugmaker Novo Nordisk. The exhibition, he said, represents the many stops, starts and setbacks people find when trying to lose weight — it can sort of feel like getting lost in a maze.Yet, in many countries, including Britain, companies can promote their brands via so-called “disea","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"cnn_highlight","url":"https://edition.cnn.com/2026/07/21/business/glp1-weight-loss-drug-advertising","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://edition.cnn.com/2026/07/21/business/glp1-weight-loss-drug-advertising","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"cnn_highlight","symbols":["BK4599","BGIA","JDOC","LU0154236417.USD","BK4585","BK4007","NVOH","BK4532","THNR","LU1093756168.USD","LU1093756325.SGD","BK4588","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","NVO","OZEM","PPH","NVOX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653621016","title":"Novo Nordisk price target raised to DKK 330 from DKK 290 at Citi","url":"https://stock-news.laohu8.com/highlight/detail?id=2653621016","media":"TIPRANKS","labels":["rating"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653621016?lang=en_us&edition=fundamental","pubTime":"2026-07-21 01:35","pubTimestamp":1784568951,"startTime":"0","endTime":"0","summary":"Citi analyst Graham Parry raised the firm’s price target on Novo Nordisk (NVO) to DKK 330 from DKK 290 and keeps a Neutral rating on the shares. Pu...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/novo-nordisk-price-target-raised-to-dkk-330-from-dkk-290-at-citi-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/novo-nordisk-price-target-raised-to-dkk-330-from-dkk-290-at-citi-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"rating","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4599","BK4007","NVOH","IE00BZ1G4Q59.USD","BK4588","LU1093756168.USD","BK4585","OZEM","NVOX","NVO","IE00BKVL7J92.USD","LU1093756325.SGD","PPH","THNR","LU0154236417.USD","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653127872","title":"Novo Nordisk A/S Stock Falls Monday, Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2653127872","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653127872?lang=en_us&edition=fundamental","pubTime":"2026-07-21 00:02","pubTimestamp":1784563320,"startTime":"0","endTime":"0","summary":"This article was automatically generated using Dow Jones technology.Shares of Novo Nordisk A/S slipped 0.6% to DKK328.00 Monday on what proved to be an overall poor trading session for the stock market, with the OMX Nordic 40 Index falling 0.3% to 2,676.94.This was the stock's second consecutive day of losses.The company closed DKK136.60 short of its 52-week high of DKK464.60, which the company reached on July 28, 2025.Trading volume was 3,239,463, compared to the 50-day average trading volume of 5,231,589.Data source: Dow Jones Market Data, FactSet Dow Jones NewswiresJuly 20, 2026 12:02 ET Copyright  2026 Dow Jones & Company, Inc.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4599","BK4532","NVOH","THNR","OZEM","NVOX","PPH","LU1093756168.USD","BK4007","LU0154236417.USD","IE00BZ1G4Q59.USD","LU1093756325.SGD","BK4588","NVO","IE00BKVL7J92.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652169892","title":"Update: Novo Nordisk's Wegovy Approved in India for Fatty Liver Disease Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2652169892","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652169892?lang=en_us&edition=fundamental","pubTime":"2026-07-20 21:15","pubTimestamp":1784553332,"startTime":"0","endTime":"0","summary":"Novo Nordisk's  Indian unit said Friday that India's Central Drugs Standard Control Organization has approved Wegovy injection 2.4 mg for the treatment of noncirrhotic metabolic dysfunction associated steatohepatitis, or MASH, in adults with moderate to advanced liver fibrosis along with a reduced calorie diet and increased physical activity.The approval was based on phase 3 trial data showing resolution of steatohepatitis in 63% of patients receiving Wegovy and reduction in liver fibrosis in 37% of patients, the company said.MASH develops due to excess fat buildup in the liver, causing chronic inflammation and liver damage, according to the company.Shares of Novo Nordisk were up 0.2% pre-bell Monday.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","NVOX","BK4532","IE00BKVL7J92.USD","LU1093756325.SGD","NVO","LU0154236417.USD","OZEM","THNR","NVOH","BK4585","IE00BZ1G4Q59.USD","LU1093756168.USD","BK4007","BK4599","PPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652972732","title":"Novo Nordisk (0QIU) Receives a Hold from Deutsche Bank","url":"https://stock-news.laohu8.com/highlight/detail?id=2652972732","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652972732?lang=en_us&edition=fundamental","pubTime":"2026-07-20 18:45","pubTimestamp":1784544338,"startTime":"0","endTime":"0","summary":"In a report released today, Emmanuel Papadakis from Deutsche Bank maintained a Hold rating on Novo Nordisk, with a price target of DKK290.00. Accor...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/novo-nordisk-0qiu-receives-a-hold-from-deutsche-bank-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/novo-nordisk-0qiu-receives-a-hold-from-deutsche-bank-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4588","OZEM","BK4599","BK4007","LU1093756325.SGD","PPH","IE00BKVL7J92.USD","THNR","NVOX","NVOH","NVO","LU0154236417.USD","IE00BZ1G4Q59.USD","LU1093756168.USD","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652267239","title":"Novo Nordisk Guidance in Focus","url":"https://stock-news.laohu8.com/highlight/detail?id=2652267239","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652267239?lang=en_us&edition=fundamental","pubTime":"2026-07-20 14:14","pubTimestamp":1784528040,"startTime":"0","endTime":"0","summary":"0613 GMT - Novo Nordisk's full-year guidance will be the focus of the company's upcoming earnings report, Citi analysts write. Key will be if, and by how much, the company raises its outlook given strong prescription trends of the Wegovy pill and injection, Citi adds. The bank thinks a guidance raise is expected by the market and priced in. Citi forecasts second-quarter adjusted operating income of 27.2 billion Danish kroner, down 9% at constant currencies, with sales 1% lower at 72.7 billion kroner. It expects continued price pressure in both the obesity and diabetes franchises, partially offset by a continued strong performance of the Wegovy weight-loss pill. It raises its target price on the stock to 330 kroner from 290 kroner and keeps its neutral rating. Shares closed at 329.90 kroner.  Dow Jones NewswiresJuly 20, 2026 02:14 ET Copyright  2026 Dow Jones & Company, Inc.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PPH","NVOX","LU1093756325.SGD","BK4532","BK4007","NVOH","IE00BZ1G4Q59.USD","BK4585","LU1093756168.USD","THNR","BK4599","BK4588","LU0154236417.USD","OZEM","NVO","IE00BKVL7J92.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652823653","title":"Trump's FDA May Soon Back Peptides. Should You Buy In?","url":"https://stock-news.laohu8.com/highlight/detail?id=2652823653","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652823653?lang=en_us&edition=fundamental","pubTime":"2026-07-18 09:31","pubTimestamp":1784338260,"startTime":"0","endTime":"0","summary":"The small-chain amino acids have picked up online fans, particularly in the workout and wellness worlds. One big backer: HHS Secretary Robert F. Kennedy Jr. Some on Wall Street see a potentially large","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["THNR","HIMZ","BK4532","HIYY","NVOH","NVO","BK4588","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","LU1093756168.USD","BK4007","BK4599","PPH","OZEM","LU1093756325.SGD","LU0154236417.USD","NVOX","BK4196","HIMS","HIMY","BK4585","HEAL","HMYY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652284029","title":"Novo Nordisk’s CagriSema Trial Wraps Up: What Completed Phase 3 Data Could Mean for NVO","url":"https://stock-news.laohu8.com/highlight/detail?id=2652284029","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652284029?lang=en_us&edition=fundamental","pubTime":"2026-07-18 00:30","pubTimestamp":1784305846,"startTime":"0","endTime":"0","summary":"Novo Nordisk ($NVO) announced an update on their ongoing clinical study. The phase 3 study “Efficacy and Safety of Co-administered Cagrilintide and...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/novo-nordisks-cagrisema-trial-wraps-up-what-completed-phase-3-data-could-mean-for-nvo?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/novo-nordisks-cagrisema-trial-wraps-up-what-completed-phase-3-data-could-mean-for-nvo?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4599","BK4532","NVOH","THNR","OZEM","NVOX","PPH","LU1093756168.USD","BK4007","LU0154236417.USD","IE00BZ1G4Q59.USD","LU1093756325.SGD","BK4588","NVO","IE00BKVL7J92.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652528441","title":"Novo Nordisk to Launch Lower-cost Ozempic Copy in South Africa","url":"https://stock-news.laohu8.com/highlight/detail?id=2652528441","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652528441?lang=en_us&edition=fundamental","pubTime":"2026-07-18 00:18","pubTimestamp":1784305121,"startTime":"0","endTime":"0","summary":"Novo Nordisk to launch lower-cost Ozempic copy in South AfricaLaunch set for July 27Novo said copy uses Ozempic's ingredient, production process and injection deviceSurging GLP-1 demand creates 'grey ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260717:nL8N43I26A:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU2552382132.HKD","LU2750360997.AUD","LU2168564065.EUR","NVO","SGXZ81514606.USD","SG9999014880.SGD","ELIL","LU2462591350.SGD","IE00B2B36J28.USD","LU0210536198.USD","BK4516","LU2211815571.USD","IE00B775H168.HKD","IE00BFSS8Q28.SGD","LU1291159041.SGD","MEDX","BK4534","LU2089284900.SGD","IE00BJJMRZ35.SGD","IE00BKDWB100.SGD","WDNA","AGNG","RXL","LU2023251221.USD","LU1548497426.USD","LU2552382058.USD","LU2461242641.AUD","LU0079474960.USD","IE0004445015.USD","LU1868836914.USD","LU2028103732.USD","LU0323591593.USD","BK4532","LU1629891620.HKD","LU0672654240.SGD","LU0820561818.USD","LU1868837300.USD","LU1551013342.USD","LU2896262040.SGD","LU1035775433.USD","LU2361044865.SGD","LU0256863811.USD","LU0823434740.USD","LU2111349929.HKD","FTXH","LU0786609619.USD","LU2417539215.USD","LU2108987350.USD","BK4588","MEDI","LU0198837287.USD","HRTS","LU0154236417.USD","LU2602419157.SGD","IE00BJT1NW94.SGD","SGXZ99366536.SGD","LU1127390331.HKD","LU0417517546.SGD","LU1974910355.USD","LU1868837136.USD","IE00B7KXQ091.USD","LU1057294990.SGD","LU2471134523.USD","LU0345770993.USD","IE00BK4W5M84.HKD","LLII","LU2756315664.SGD","LU0106261372.USD","LU1232071149.USD","LU2168564149.EUR","LU0354030511.USD","IE00BWXC8680.SGD","PJP","LU0320765059.SGD","LU0203202063.USD","LU2023250504.SGD","LU0471298777.SGD","BK4581","LU0289739699.SGD","LU0094547139.USD","LU0225283273.USD","LU2089984988.USD","LU0234572021.USD","SG9999015978.USD","LU2456880835.USD","PPH","LU2491049909.HKD","SG9999014914.USD","LU0114720955.EUR","LU2756315318.SGD","SGXZ57979304.SGD","LU2471134879.HKD","LU0006306889.USD","LU0109391861.USD","LU2106854487.HKD","LU2361045086.USD","ILDR","LU0640476718.USD","LU2357305700.SGD","LU2746668974.SGD","LU0889565916.HKD","LU0466842654.USD","LLYZ","LU1988902786.USD","IE00BJJMRX11.SGD","SG9999015952.SGD","BK4007","SG9999001176.USD","SGXZ31699556.SGD","IE00BJJMRY28.SGD","LU2168564495.EUR","CANC","LU1023059063.AUD","LU2265009873.SGD","LU0096364046.USD","LU1720051017.SGD","LU2471134796.USD","LU0256863902.USD","LU1551013425.SGD","LU0964807845.USD","BK4599","ELIS","LU1720051108.HKD","LU2168564222.USD","IE00BFSS7M15.SGD","LU2236285917.USD","LU2471134952.CNY","JDOC","IE00BN29S564.USD","LU0820561909.HKD","XLV","CURE","LU2746668461.USD","LU0353189763.USD","LU0432979614.USD","GB00BDT5M118.USD","LLY","IE00B1XK9C88.USD","LU0823434583.USD","LU2089283258.USD","LU0174119429.USD","IXJ","LU1989771016.USD","LU2237443895.HKD","SG9999018857.SGD","LU0122379950.USD","LU0316494557.USD","IE0009355771.USD","SG9999014898.SGD","SG9999001176.SGD","THNR","LU2023250330.USD","LU1917777945.USD","LU0456855351.SGD","LU0354030438.USD","LU1868836757.USD","LU2237438978.USD","LU0203201768.USD","LU2491050071.SGD","SG9999018865.SGD","IE00B1BXHZ80.USD","LLYX","IE0001KFT4U8.USD","IE00BK4W5L77.USD","LU0385154629.USD","LU2462157665.USD","IE00B4R5TH58.HKD","LU0353189680.USD","SG9999017495.SGD","SGXZ51526630.SGD","LU0320765992.SGD","SG9999015986.USD","LU2361044949.HKD","LU2491050154.USD","LU1267930730.SGD","LU2168563687.JPY","LU2264538146.SGD","LU0943347566.SGD","NVOH","IE00B4JS1V06.HKD","IE0002141913.USD","LU1868836591.USD","LU0109394709.USD","LU2360106947.USD","LU1323610961.USD","LU0708995401.HKD","LU0345770308.USD","LU0061475181.USD","LU1814569148.SGD","LU0158827781.USD","LU1093756168.USD","IHE","IE00BZ1G4Q59.USD","NVOX","LU0683600562.USD","LU1069344957.HKD","LU1366192091.USD","LU0471298694.HKD","LU2750360641.GBP","LU1712237335.SGD","OZEM","IE0005OL40V9.USD","LU2112291526.USD","LU1623119135.USD","LU2237443978.SGD","LU0882574055.USD","LU2468319806.SGD","LU2213496289.HKD","LU0689472784.USD","LU2552382215.SGD","IE0004445239.USD","LU2271345857.HKD","SG9999015945.SGD","LU2237443549.SGD","LU0882574139.USD","FHLC","LU2087625088.SGD","LU1061106388.HKD","GDOC","LU0266013472.USD","LU0823416689.USD","IE00BKVL7J92.USD","LU0133085943.USD","LU1064131342.USD","LU2324357040.USD","LU2237443382.USD","VHT","SG9999013999.USD","SG9999014906.USD","IE00BFTCPJ56.SGD","LU2237443622.USD","LU1804176565.USD","LU2237443465.HKD","LU0787776722.HKD","LU0058720904.USD","LU1983299246.USD","LU0158827948.USD","IE00BKPKM429.USD","BK4533","LU0238689110.USD","LU1280957306.USD","LU0097036916.USD","LU2063271972.USD","IE00BJLML261.HKD","IYH","LU0820562030.AUD","LU1145028129.USD","LU1093756325.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652828490","title":"Novo Nordisk A/S Stock Falls Friday, Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2652828490","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652828490?lang=en_us&edition=fundamental","pubTime":"2026-07-18 00:02","pubTimestamp":1784304120,"startTime":"0","endTime":"0","summary":"This article was automatically generated using Dow Jones technology.Shares of Novo Nordisk A/S slipped 1.8% to DKK329.90 Friday on what proved to be an overall poor trading session for the stock market, with the OMX Nordic 40 Index falling 0.4% to 2,685.19.The stock's fall  snapped a two-day winning streak.The company closed DKK134.70 below its 52-week high of DKK464.60, which the company reached on July 28, 2025.Trading volume was 4,779,556, compared to the 50-day average trading volume of 5,289,955.Data source: Dow Jones Market Data, FactSet Dow Jones NewswiresJuly 17, 2026 12:02 ET Copyright  2026 Dow Jones & Company, Inc.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVOH","IE00BZ1G4Q59.USD","LU1093756168.USD","OZEM","NVOX","IE00BKVL7J92.USD","BK4588","PPH","BK4585","BK4007","BK4599","LU0154236417.USD","LU1093756325.SGD","NVO","BK4532","THNR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652028455","title":"European Equities Mixed in Friday Trading; ASML to Give Staff One-Time Bonus","url":"https://stock-news.laohu8.com/highlight/detail?id=2652028455","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652028455?lang=en_us&edition=fundamental","pubTime":"2026-07-17 23:50","pubTimestamp":1784303417,"startTime":"0","endTime":"0","summary":"European stock markets closed mixed in Friday trading with the Stoxx 600 down 0.5%, Germany's DAX shedding 0.5%, the UK's FTSE 100 edging up  0.1%, France's CAC 40 declining 0.5%, and the Swiss Market","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE0002270589.USD","LU0868494617.USD","IE00B3CCJ963.GBP","LU0889566641.SGD","ASMH","LU2087621335.USD","NVO","LU0511384066.AUD","LU0320765646.SGD","LU1244550494.USD","LU2433249047.HKD","LU0823434740.USD","LU1496350502.SGD","GSID","LU0122379950.USD","LU0957791311.USD","IE00B19Z3581.USD","LU0426412945.USD","LU1023059063.AUD","LU1093756325.SGD","XLV","LU1280957306.USD","LU1670627923.USD","LU2237443465.HKD","LU2133065610.SGD","LU1983299246.USD","FFGX","BK4534","LU0061474960.USD","LU0943347566.SGD","IXJ","LU0708994859.HKD","EFA","SG9999015978.USD","IE00B4R5TH58.HKD","SG9999015986.USD","LU2089284900.SGD","LU0256863902.USD","LU2063271972.USD","LU2129689605.HKD","LU0689472784.USD","LU1201861249.SGD","LU1989772840.SGD","CGIC","FENI","LU0823416689.USD","LU2023251221.USD","BK4555","DIG","ABBV","LU2237443978.SGD","FENY","IE000F7OJYX1.SGD","IE00BGHQF524.EUR","IE00B7SZLL34.SGD","LU0029864427.USD","LU2125154778.USD","LU2506951958.HKD","LU1037948541.HKD","LU0949170772.SGD","IE00BLSP4239.USD","LU0211328371.USD","NVOX","LU0792757196.USD","LU0345780950.USD","MEDX","LU0472753341.HKD","LU2954938101.SGD","LU0965509010.AUD","BK4599","LU0154236417.USD","LU2129689431.USD","LU0114720955.EUR","LU2468319806.SGD","LU1989772923.USD","LU2506952170.USD","IE00B2Q91V27.USD","IE00BVYPNW00.USD","LU0289739343.SGD","LU0300736492.USD","LU1291159041.SGD","IE0002141913.USD","IE00BZ1G4Q59.USD","LU0456855351.SGD","LU0130517989.USD","LU0795875169.SGD","SG9999003800.SGD","LU1201861165.SGD","LU2112291526.USD","LU0234570918.USD","IE000MB6IJN5.SGD","LU0130103400.USD","LU1064131342.USD","LU0432979614.USD","LU1815333072.USD","LU0823434583.USD","LU1037948897.HKD","LU2089283258.USD","LU2543165471.USD","AGNG","LU0689626769.HKD","SG9999011175.SGD","BK4085","IE00BFTCPJ56.SGD","FHLC","IE00BBT3K403.USD","ASMU","LU0640476718.USD","LU0456854461.SGD","LU0417517546.SGD","LU0788109394.HKD","LU0648001328.SGD","BK4585","IE00BVYPNV92.GBP","LU1003077747.HKD","IE00BD6J9T35.USD","LU0345781412.USD","IEO","LU0345774631.USD","BK4007","IE00B19Z3B42.SGD","LU0868494708.USD","LU2129689514.USD","SG9999015945.SGD","BK4533","LU0965508806.USD","LU1839511570.USD","XPEV","BK4566","LU0965509101.SGD","BK4551","LU0661504455.SGD","LU1061106388.HKD","LU1267930490.SGD","SG9999001440.SGD","LU2237443895.HKD","IE00BDGV0183.EUR","LU1934455194.USD","LU2237443549.SGD","ASMG","FTXN","LU0006061336.USD","LU0098860793.USD","LU1732800096.USD","LU0965509283.SGD","LU2264538146.SGD","LU0980610538.SGD","IE000BZT7R73.USD","LU2999663052.SGD","LU2237443622.USD","NVOH","LU2347655156.SGD","LU0345774391.USD","BK4543","LU0203345920.USD","IYH","RXL","LU1988902786.USD","LU0130102774.USD","BK4570","LU1732799900.SGD","BK4588","LU2462591277.SGD","LU1929549753.HKD","LU0143551892.USD","IE00BGHQF631.EUR","LU0058720904.USD","LU0256331488.USD","LU0289739699.SGD","IE00BKVL7J92.USD","LU0314106906.USD","IEFA","IE00BLSP4452.SGD","LU1934455863.HKD","LU2360032135.SGD","LU0823417737.USD","OZEM","IE00BJJMRZ35.SGD","BK4213","JDOC","09868","ILOW","LU1734074674.USD","BK4532","LU0128525929.USD","LU0861579265.USD","VDE","LU1923622614.USD","IE00B2B36J28.USD","IE0000B7K699.USD","LU0084288322.USD","BK4099","IE00B42XCP33.USD","LU0950375773.USD","SG9999002521.SGD","LU0057025933.USD","LU0069063385.USD","LU0203347892.USD","LU0882574055.USD","LU0097036916.USD","BK4147","LU0198837287.USD","LU0256863811.USD","03165","LU2089984988.USD","PJP","ASML","LU0266512127.USD","LU1043141123.HKD","WEEI","ESPO","LU1718418525.SGD","EA","IE0009355771.USD","LU0170899867.USD","LU0820561818.USD","LU0994945656.USD","LU1093756168.USD","IE00BN8TJ469.HKD","IE000WAW04H5.SGD","IE00B3PB1722.GBP","LU0477156953.USD","LU2125909593.SGD","LU0310800379.SGD","LU1496350171.SGD","LU2506951875.HKD","BK4505","LU1551013342.USD","LU0985320562.USD","LU1244550221.USD","XLE","IXC","PPH","VHT","IGE","LU0795875086.SGD","LU1551013425.SGD","LU2247934214.USD","IE000SO60NU8.SGD","IE0004445239.USD","LU0553294199.USD","LU0738911758.USD","BK4550","IE00BSNM7G36.USD","DBEF","BK4526","LU0122376428.USD","LU0630314457.HKD","LU1043141396.HKD","LU1267930813.SGD","LU1430594728.SGD","LU0310799852.SGD","LU0234572021.USD","LU0820561909.HKD","LU0300736062.USD","BNGE","DBEU","COP","LU1074936037.SGD","LU1121112475.USD","LU2125154935.USD","LU0648000940.SGD","LU1506573853.SGD","LU2125909247.SGD","LU2357627491.SGD","HERO","LU0368265418.SGD","BK4139","LU1267930573.SGD","XPEG","BK4559","FTXH","LU1057294990.SGD","LU0211327993.USD","LU0912757837.SGD","LU1585245621.USD","LU0942090050.USD","LU2237443382.USD","LU1244550577.SGD","LU1670628061.USD","OILT","SG9999015952.SGD","LU2506952097.USD","LU0859254822.USD","IE00BJT1NW94.SGD","LU1162221912.USD","BK4581","LU1989771016.USD","BK4577","LU0426417589.USD","LU0545039389.USD","LU0823417653.USD","LU0158827948.USD","LU0238689110.USD","NERD","IYE","THNR","EVS.SI","FCG","LU0124676726.USD","LU0289961442.SGD","LU1934455277.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652286740","title":"European Pharma Stocks' Underperformance Shouldn't Last","url":"https://stock-news.laohu8.com/highlight/detail?id=2652286740","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652286740?lang=en_us&edition=fundamental","pubTime":"2026-07-17 22:13","pubTimestamp":1784297580,"startTime":"0","endTime":"0","summary":"1413 GMT - European pharma stocks are lagging behind the broader market, but the sector should benefit as investors start to look for trades beyond big tech, Intron Health's Naresh Chouhan and Dominic Rose say in a research note. This year's underperformance came after pricing deals with the Trump administration at the end of last year boosted the sector, Intron says. \"We do not believe investors have fallen out of love with pharma, it is just that many believe the sector is up with events for now,\" the analysts say. Upcoming strategy updates from companies like GSK, Novo Nordisk and Roche, and potential gains from AI should help pharma stocks, they add. Intron says it favors UCB, AstraZeneca, Roche and Novartis in the near term. The Stoxx Europe 600 Health Care index rises 0.3%.  Dow Jones NewswiresJuly 17, 2026 10:13 ET Copyright  2026 Dow Jones & Company, Inc.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","IE00B3T34201.USD","LU0708994859.HKD","IE00B2B36J28.USD","OZEM","LU0058720904.USD","PPH","LU0208291251.USD","IE0002141913.USD","LU0432979614.USD","CANC","BK4599","IE00BKVL7J92.USD","LU0310800379.SGD","LU2237443465.HKD","LU0320765489.SGD","BK4585","BK4007","LU0289739699.SGD","RHHBY","THNR","HRTS","NVO","LU1093756325.SGD","LU0128525929.USD","LU0211331839.USD","LU0070302665.USD","LU2462157665.USD","AZN","IE0009355771.USD","EPV","NVOH","LU0320765992.SGD","LU0889565916.HKD","LU2237443622.USD","AZNH","IE00BJJMRZ35.SGD","MEDX","LU1829250122.USD","03165","LU0154236417.USD","LU2237443382.USD","IE00BZ1G4Q59.USD","BK4578","LU2456880835.USD","GSK","GSKH","BK4588","LU2237443895.HKD","LU2236285917.USD","LU2417539215.USD","GSK.UK","NVS","IE00B4R5TH58.HKD","NVOX","LU1093756168.USD","LU2237443978.SGD","BK4532","IE00BFTCPJ56.SGD","IE00BJT1NW94.SGD","LU0109394709.USD","LU0029864427.USD","LU2468319806.SGD","LU2089984988.USD","LU2237443549.SGD","LU1267930573.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652285185","title":"Market Chatter: Novo Nordisk's Wegovy Approved for Fatty Liver Disease Treatment by India's Drug Regulator","url":"https://stock-news.laohu8.com/highlight/detail?id=2652285185","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652285185?lang=en_us&edition=fundamental","pubTime":"2026-07-17 21:18","pubTimestamp":1784294292,"startTime":"0","endTime":"0","summary":"Novo Nordisk's  Wegovy received approval from India's drug regulator for use in patients with metabolic dysfunction-associated steatohepatitis, or MASH, Reuters reported Friday.MASH is a serious fatty liver disease that can cause inflammation and liver damage, according to the report.Novo Nordisk did not immediately respond to MT Newswires' request for comment.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","BK4588","OZEM","BK4599","BK4007","LU1093756325.SGD","PPH","IE00BKVL7J92.USD","THNR","NVOX","NVOH","NVO","LU0154236417.USD","IE00BZ1G4Q59.USD","LU1093756168.USD","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652294664","title":"Cboe data shows mixed options sentiment in Novo Nordisk with shares up 2.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2652294664","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652294664?lang=en_us&edition=fundamental","pubTime":"2026-07-17 02:05","pubTimestamp":1784225127,"startTime":"0","endTime":"0","summary":"Cboe data shows mixed options sentiment in Novo Nordisk (NVO), with shares up $1.06, or 2.11%, near $51.62. Options volume running well above avera...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cboe-data-shows-mixed-options-sentiment-in-novo-nordisk-with-shares-up-2-11-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cboe-data-shows-mixed-options-sentiment-in-novo-nordisk-with-shares-up-2-11-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["THNR","NVOX","IE00BKVL7J92.USD","BK4007","NVO","NVOH","BK4588","IE00BZ1G4Q59.USD","PPH","OZEM","BK4585","BK4532","LU1093756325.SGD","LU1093756168.USD","BK4599","LU0154236417.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651423936","title":"European Equities Traded in the US as American Depositary Receipts Edge Lower Thursday","url":"https://stock-news.laohu8.com/highlight/detail?id=2651423936","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651423936?lang=en_us&edition=fundamental","pubTime":"2026-07-16 23:16","pubTimestamp":1784214983,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were slightly lower on Thursday morning, down 0.07% to 1,911.26 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by pharmaceutical company Novo Nordisk  and drink and brewing company Anheuser-Busch Inbev , which rose 1.9% and 0.9% respectivelyThey were followed by pharmaceutical company Novartis , which added 0.8%.The decliners from continental Europe were led by tech companies Nokia  and Ericsson , which fell 7.8% and 1.8% respectively.They were followed by bank Santander , which shed 1.5%.From the UK and Ireland, the gainers were led by advertising and PR agency WPP  and telecom giant Vodafone , which rose 3.8% and 3% respectively. They were followed by beverage company Diageo , which added 2.5%.The decliners from the UK and Ireland were led by semiconductor company Arm  and pharmaceutical company Compass Pathways , which lost 6.9% and 2.1% respectively.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4609","LU1232071149.USD","ARMW","IE00BJJMRZ35.SGD","BK4559","IE0002141913.USD","GSIB","BK4585","BK4141","BK4169","ERIC","OZEM","BK4158","LU2543165471.USD","LU0266013472.USD","BK4139","BK4554","LNOK","PPH","BK4591","NVO","IE00BKVL7J92.USD","NVOH","BK4515","SPRX","IE00B4R5TH58.HKD","AIPI","IE00BFTCPJ56.SGD","BK4007","WPP","BUD","IE00BJT1NW94.SGD","IE00BMPRXN33.USD","LU0070302665.USD","LU0211331839.USD","LU0208291251.USD","LU1093756168.USD","NVS","PSIL","BK4132","DEO","NVOX","LU0006061336.USD","LU0154236417.USD","IE0009355771.USD","THNR","IE00BMPRXR70.SGD","BK4020","MEDX","CMPS","LU0320765489.SGD","NOK","BK4599","LU0081259029.USD","BK4009","BK4207","ARMU","LU0348723411.USD","TRFK","BK4532","IE00BZ1G4Q59.USD","VOD","ARMG","BK4521","BK4578","BK4588","IE00BMPRXQ63.HKD","LU1093756325.SGD","DGE.UK","ARM","BK4543","QQQA","BK4547","SAN","IE00B2B36J28.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1181840560","title":"South Korea Implements New Rules to Curb Risks from Single-Stock Leveraged ETFs","url":"https://stock-news.laohu8.com/highlight/detail?id=1181840560","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1181840560?lang=en_us&edition=fundamental","pubTime":"2026-07-16 21:12","pubTimestamp":1784207530,"startTime":"0","endTime":"0","summary":"South Korea's Financial Services Commission (FSC) has announced a set of regulatory measures aimed at managing the risks associated with single-stock leveraged exchange-traded funds (ETFs). The...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SPYM","SMAX","UPRO","PLTD","AAPD","VOO","AAPU","SPDN","SDS","IVV","SPY","PLTW","SPUU","MZZ","SPXU","BK4585","NVOH","FNGG","AAPX","BK4588","AAPB","PLYY","YSPY","SPYQ","DMAX","MVPL","SSO","PLTG","PLTZ","PLTA","SOXW","NVOX","AAPW","HIBL","SPXS","SPYH","PTIR","MMAX","AAPY","SPXL","PLOO","PLTY","APLY","SPYU","PLTU","PLTI","SH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651413709","title":"United Laboratories Unit Receives $13.5 Million Milestone Payment From Novo Nordisk","url":"https://stock-news.laohu8.com/highlight/detail?id=2651413709","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651413709?lang=en_us&edition=fundamental","pubTime":"2026-07-16 13:04","pubTimestamp":1784178245,"startTime":"0","endTime":"0","summary":"United Laboratories International  said its subsidiary United Biotechnology received a $13.5 million milestone payment from Novo Nordisk related to the global Phase II clinical trial of UBT251 Injection for overweight or obesity treatment, according to a Thursday Hong Kong bourse filing.Shares of the pharmaceutical company were up over 2% in recent trade.The payment was received under an exclusive license agreement for UBT251. The company is eligible for up to $1.8 billion in development and sales milestone payments, along with tiered royalties tied to annual net sales.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["OZEM","PPH","BK4599","IE00BKVL7J92.USD","BK4585","BK4007","THNR","NVO","LU1093756325.SGD","NVOH","BK1191","LU0154236417.USD","IE00BZ1G4Q59.USD","BK4588","NVOX","IE00B3M56506.USD","LU1093756168.USD","03933","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651841332","title":"United Laboratories Secures Novo Nordisk Milestone for Obesity Drug UBT251","url":"https://stock-news.laohu8.com/highlight/detail?id=2651841332","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651841332?lang=en_us&edition=fundamental","pubTime":"2026-07-16 12:07","pubTimestamp":1784174837,"startTime":"0","endTime":"0","summary":"The latest announcement is out from The United Laboratories International Holdings ( ($HK:3933) ). The United Laboratories International Holdings a...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/united-laboratories-secures-novo-nordisk-milestone-for-obesity-drug-ubt251?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/united-laboratories-secures-novo-nordisk-milestone-for-obesity-drug-ubt251?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NVOX","OZEM","IE00B3M56506.USD","LU1093756168.USD","BK4585","BK4532","NVO","LU0154236417.USD","THNR","BK4588","03933","BK4007","NVOH","IE00BZ1G4Q59.USD","BK4599","IE00BKVL7J92.USD","BK1191","LU1093756325.SGD","PPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651607254","title":"Moderately bullish activity in Novo Nordisk with shares up 2.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2651607254","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651607254?lang=en_us&edition=fundamental","pubTime":"2026-07-16 01:45","pubTimestamp":1784137514,"startTime":"0","endTime":"0","summary":"Moderately bullish activity in Novo Nordisk (NVO), with shares up $1.21, or 2.46%, near $50.27. Options volume running well above average with 63k ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/moderately-bullish-activity-in-novo-nordisk-with-shares-up-2-46-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/moderately-bullish-activity-in-novo-nordisk-with-shares-up-2-46-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4588","OZEM","BK4599","BK4007","LU1093756325.SGD","PPH","IE00BKVL7J92.USD","THNR","NVOX","NVOH","NVO","LU0154236417.USD","IE00BZ1G4Q59.USD","LU1093756168.USD","BK4532"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":10,"totalSize":200,"code":"91000000","status":"200"}]}}